The creator of CRISPR babies is flirting again with infamy, this time through a mysterious alliance with an Internet-savvy ...

Evidence-based medicine: good. Taking away vaccines from people who might benefit: not so much. This week, two new leaders at the US Food and Drug Administration announced plans to limit access to ...

The company claims its ability to tackle complex, multistep problems paves the way for much more proficient AI agents.

The corporate race to amass computing resources to train and run artificial intelligence models and store information in the ...